Haymaker Acquisition News Today

Key Insights Institutions' substantial holdings in Haymaker Acquisition 4 implies that they have significant influence...

By Josh Beckerman Biote shares rose 15% Wednesday as the company agreed to settle litigation with founder and stockholder Gary S. Donovitz. The stock was...

Certain Class B Ordinary Shares of Haymaker Acquisition Corp. 4 are subject to a Lock-Up Agreement Ending on 21-JAN-2024. These Class B Ordinary Shares will be under lockup for 180 days starting from...

Total Q3 Revenues of $216.3 Million, Income from Operations of $17.0 Million and Adjusted EBITDA of $24.9 Million Introduces Q4 2023 Guidance for Revenues of $193 - $198 Million and Adjusted EBITDA...

/PRNewswire/ -- Haymaker Acquisition Corp. 4 (NYSE: HYAC U) (the "Company") announced today that, commencing September 15, 2023, holders of the units sold in...

By Stephen Nakrosis Special purpose acquisition company Haymaker Acquisition Corp. 4 said its units will begin trading on the New York Stock Exchange on July...

09.06.2023 - Biote (NASDAQ: BTMD) (the “Company,” “we” or “us”), a leading solutions provider in preventive healthcare through the delivery of personalized hormone therapy, today announced the expiration and results of its previously announced (i) offer to each ... Seite 1

FinancialContent fully hosted finance channel

Biote , a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced that it has commenced an exchange offer and consent solicitation... | May 9, 2023

Total Revenues of $182.5 Million, Income from Operations of $11.2 Million and Adjusted EBITDA of $19.3 Million Introduces Q2 2023 Guidance for Revenues of $185 - $190 Million and Adjusted EBITDA of... | May 3, 2023